We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
Price data last checked 102 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Product Specifications
- Format
- paperback
- ASIN
- B01GEP5JBO
- Domain
- Amazon UK
- Release Date
- 30 September 2015
- Listed Since
- 31 May 2016
Similar Products You Might Like
97% match
The 2016-2021 Outlook for Neurostimulation Devices in the United States
£595.00
25 Jan 2026
97% match
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
£595.00
12 Jan 2026
96% match
The 2016-2021 Outlook for Erythropoietins in the United States
£595.00
01 Feb 2026
96% match
The 2016-2021 Outlook for Lou Gehrig's Disease Drugs in the United States
£595.00
25 Jan 2026
96% match
The 2016-2021 Outlook for Motion Sickness Medications in the United States
£595.00
25 Jan 2026
96% match
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States
£595.00
24 Jan 2026
96% match
The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in the United States
£595.00
25 Jan 2026
96% match
The 2016-2021 Outlook for Nanomedicine in the United States
£595.00
23 Jan 2026
96% match
The 2016-2021 Outlook for Stem Cell Products in the United States
£595.00
05 Feb 2026
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
£595.00
28 Feb 2026
96% match
The 2016-2021 Outlook for Online Social Interaction Services in the United States
£595.00
24 Jan 2026
96% match
The 2016-2021 Outlook for Phytosterols in the United States
£595.00
22 Jan 2026
96% match
The 2016-2021 Outlook for Physicians' Services in the United States
£595.00
26 Jan 2026
96% match
The 2016-2021 Outlook for Pulmonary Drug Delivery Systems in the United States
£595.00
30 Jan 2026
96% match
The 2016-2021 Outlook for Skeletal Muscle Relaxant Pharmaceutical Preparations in the United States
£595.00
16 Feb 2026
96% match
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in the United States
£595.00
10 Dec 2025
96% match
The 2016-2021 Outlook for Monoglycerides in the United States
£595.00
06 Feb 2026
96% match
The 2016-2021 Outlook for OTC Healthcare Products in the United States
£595.00
25 Jan 2026
96% match
The 2016-2021 Outlook for Anti-Migraine Drugs in the United States
£595.00
22 Jan 2026
96% match
The 2016-2021 Outlook for Topical Antiseptic Medications in the United States
£595.00
26 Jan 2026
96% match
The 2016-2021 Outlook for Interactive Whiteboards in the United States
£595.00
23 Jan 2026
96% match
The 2016-2021 Outlook for Optoelectronics in the United States
£595.00
26 Jan 2026
96% match
The 2016-2021 Outlook for Luxury Goods in the United States
£595.00
23 Jan 2026
96% match
The 2016-2021 Outlook for Nanobiotechnology Solutions in the United States
£595.00
13 Jan 2026